| Trial ID: | L0451 |
| Source ID: | IRCT20191006044993N1
|
| Associated Drug: |
Plantago
|
| Title: |
Comparison of the effect of plantago major with placebo on liver enzymes in patients with nonalcoholic fatty liver disease(NAFLD): a double-blind randomized clinical trial
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver Disease. <br>Non Alcoholic Fatty Liver Disease;K76-0
|
| Interventions: |
Intervention 1: Intervention group:In the intervention group in addition to lifestyle training and in-person follow-up once every 2 weeks, the 500 mg capsule of Plantago major seed twice per day is given, 2 capsules each time, orally for 12 weeks.The see
|
| Outcome Measures: |
Comprison of the Plantago major seed with Placebo on ALT enzyme(Alanin trasaminase) in Non Alcoholic Fatty Liver Disease (NAFLD). Timepoint: Onset, 6th and 12th week of study.(End of study). Method of measurement: Hitachi 912 instrument.;Comprison of the Plantago major seed with Placebo on AST enzyme(Aspartate transaminase) in Non Alcoholic Fatty Liver Disease (NAFLD). Timepoint: Liver enzymes measurement at baseline, 6th and 12th weeks (end of study). Method of measurement: Hitachi 912 instrument.nan
|
| Sponsor/Collaborators: |
Iran University of Medical Sciences
|
| Gender: |
All
|
| Age: |
12 years80 years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
80
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The block randomization method is used using 4-way blocks and a random number table.Interventions A and B define six b
|
| Start Date: |
05/11/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
17 December 2019
|
| Locations: |
Iran (Islamic Republic of);Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/42817
|
